These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 9449388

  • 1. Bradykinin blocks angiotensin II-induced hypertrophy in the presence of endothelial cells.
    Ritchie RH, Marsh JD, Lancaster WD, Diglio CA, Schiebinger RJ.
    Hypertension; 1998 Jan; 31(1):39-44. PubMed ID: 9449388
    [Abstract] [Full Text] [Related]

  • 2. Acute antihypertrophic actions of bradykinin in the rat heart: importance of cyclic GMP.
    Rosenkranz AC, Hood SG, Woods RL, Dusting GJ, Ritchie RH.
    Hypertension; 2002 Oct; 40(4):498-503. PubMed ID: 12364353
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide.
    Ritchie RH, Schiebinger RJ, LaPointe MC, Marsh JD.
    Am J Physiol; 1998 Oct; 275(4):H1370-4. PubMed ID: 9746487
    [Abstract] [Full Text] [Related]

  • 4. Hyperglycaemia abolishes the antihypertrophic efficacy of bradykinin in rat ventricular myocytes.
    Rosenkranz AC, Dusting GJ, Ritchie RH.
    Clin Exp Pharmacol Physiol; 1999 Jul; 26(7):519-21. PubMed ID: 10405778
    [Abstract] [Full Text] [Related]

  • 5. Endothelial dysfunction limits the antihypertrophic action of bradykinin in rat cardiomyocytes.
    Rosenkranz AC, Dusting GJ, Ritchie RH.
    J Mol Cell Cardiol; 2000 Jun; 32(6):1119-26. PubMed ID: 10888262
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor.
    Flores-Muñoz M, Smith NJ, Haggerty C, Milligan G, Nicklin SA.
    J Physiol; 2011 Feb 15; 589(Pt 4):939-51. PubMed ID: 21173078
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
    Wollert KC, Studer R, Doerfer K, Schieffer E, Holubarsch C, Just H, Drexler H.
    Circulation; 1997 Apr 01; 95(7):1910-7. PubMed ID: 9107180
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W, Schölkens BA.
    J Cardiovasc Pharmacol; 1992 Apr 01; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H, Shi S, Sun YH, Zhao YJ, Li QF, Li HZ, Wang R, Xu CQ.
    Clin Exp Pharmacol Physiol; 2009 Mar 01; 36(3):312-8. PubMed ID: 18986329
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.